Thus, the levels of several p-tau variants may indicate the state of the disease or even predict it, as well as differentiating AD from other neurodegenerative disorders [49,71,73,74,75,76,77,78,79,80,81,82,83,84,86,87,89]. This evidence concerns the gene MAPT and Alzheimer disease.